Article info
Coronary artery disease
Original article
Efficacy and safety of a routine early invasive strategy after fibrinolysis stratified by glycoprotein IIb/IIIa inhibitor use during percutaneous coronary intervention: a pre-specified subgroup analysis of the TRANSFER-AMI randomised controlled trial
- Correspondence to Dr Andrew T Yan, Division of Cardiology, St Michael's Hospital, 30 Bond Street, Donnelly 6-030, Toronto, Ontario, Canada M5B 1W8; yana{at}smh.ca
Citation
Efficacy and safety of a routine early invasive strategy after fibrinolysis stratified by glycoprotein IIb/IIIa inhibitor use during percutaneous coronary intervention: a pre-specified subgroup analysis of the TRANSFER-AMI randomised controlled trial
Publication history
- Received November 8, 2013
- Revised December 17, 2013
- Accepted December 20, 2013
- First published January 21, 2014.
Online issue publication
May 08, 2014
Article Versions
- Previous version (21 January 2014).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions